Our lipoprotein and glycoprotein test in the SEA conference
On March 17th and 18th, the 17th Conference on Hypertriglyceridemia and the 8th Conference on lipid units organized by the Spanish Society of Arteriosclerosis (SEA) took place. Dra. Daiana Ibarretxe gave a presentation entitled “Lipid and inflammatory markers in ischemia premature” in the session Dyslipidemia and cardiovascular risk in special situations. She presented the use […]
Biosfer Teslab was invited to the commemoration of the anniversary of the URV
On March 15, the 50th anniversary of university studies in Tarragona and the 30th anniversary of the creation of the Universitat Rovira i Virgili (URV) took place in the FiraReus. The event was attended by representatives of the Reus City Council, social agents, and members of the centers that form part of the URV Bellissens […]
New portofolio at Biosfer Teslab
New portofolio. At Biosfer Teslab, we are committed to constant technological innovation to always provide the best service to our customers. Our extensive experience in NMR has allowed us to include in our service portfolio the characterization of macromolecular complexes such as lipoprotein and glycoprotein profile in intact serum, low molecular weight metabolites and lipid […]
Biosfer Teslab invited to the event organised by the OEPM
On the occasion of the visit to Spain of Daren Tang, Director General of the World Intellectual Property Organization (WIPO), on 10 February, the Spanish Patent and Trademark Office (OEPM), directed by José Antonio Gil Celedonio, together with the Ministry of Culture and Sport, Ministry of Industry, Commerce and Tourism, and the Instituto de Empresa (IE School of […]
The co-founder of Biosfer Teslab stars in the ‘Beer & Business’ cycle at El Círcol
El Círcol, founded in 1852, is a recreational cultural society based in Plaça Prim in Reus. Its current president, Patrícia Terradellas Maré, has decided to rejuvenate the social mass in order to attract new members between thirty and forty years old. Thinking of the talent that the city possesses, Patricia believes that it would be […]
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease
On April 28-29, 2021, 50 scientists from different fields of expertise met for the 3rd online CIAO workshop, in which Biosfer Teslab had the great opportunity to participate.The CIAO project “Modelling the Pathogenesis of COVID-19 using the Adverse Outcome Pathway (AOP) framework” aims at building a holistic assembly of the available scientific knowledge on COVID-19 using […]
Triglyceride-rich lipoproteins and glycoproteins potential biomarkers in the development of steatosis.
Recently, metabolically associated fatty liver disease (MAFLD) has become one of the leading causes of chronic liver disease worldwide, and has become a public health challenge. This disease, defined as the accumulation of fat in the liver in the presence of metabolic dysfunction, can range from simple steatosis, which involves little inflammation, to steatohepatitis characterised […]
Biosfer Teslab invited to the Biotec seminar in the framework of the second edition of the event Casa Wallonia 2021
On 24 November, the Biotec seminar “2021 the year of biotechnology” took place in Madrid as part of the second edition of the event Casa Wallonia 2021 organised by the Representation of the Walloon Region of the Belgian Embassy in Madrid at the prestigious Carlos de Amberes Foundation in Madrid. Located in the heart of […]
Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing
Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing together with 5 other start-ups in the sector organized by Telefonica Open Future. Last year, Biosfer Teslab was selected to participate in the Tarragona Open Future where it was awarded with the second place. Open […]
Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab
From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and practice of hepatology, and to promote liver health. This year, Biosfer Teslab, together with OWL Metabolomics, University of Medicine […]
